INTRODUCTION
Vitamin D deficiency represents a major public health problem, not only because its prevalence is high (so high that it is considered a true epidemic) but also because of the considerable clinical repercussions [1] [2] [3] . Its importance concerned to calcium homeostasis and bone metabolism are well known, but, following the identification of vitamin D receptors in various cells and organs of the body, including the pancreas, macrophages, endothelium, stomach, epidermis, colon, and placenta
4
, vitamin D has been shown to have major extra-skeletal (autocrine and paracrine) effects
5
. Vitamin D treatment has also been associated with reduced rate of falls 6 , mobility, worsening of muscle function, an increased risk ical data from the controls were representative of the general population.
To identify eligible studies, we consulted the Medline, Latin-American and Caribbean Health Sciences Literature, and Excerpta Medica databases for entries up to September 2016, using the strategy outlined in Chart 1, without restricting the year of publication or language. The articles were selected through the process described in Figure 1 . We also reviewed the publications listed in the bibliographies of the articles selected. The selection, evaluation of the titles, and evaluation of the abstracts of the studies identified in the databases consulted were conducted by two investigators with experience in conducting systematic reviews. The investigators worked independently, strictly adhering to the inclusion and exclusion criteria. To extract data of interest for this review, the investigators then evaluated the remaining articles for information regarding the measurement of serum 25(OH)D concentrations; study locale; participant ages and menopausal status; sample size and selection criteria; and the methods used in the clinical and biochemical analyses. When there was disagreement between the investigators regarding the selection of studies, a third investigator was consulted. The data were compiled into a Microsoft Office Excel spreadsheet. The primary endpoint of interest was the prevalence of hypovitaminosis D, the reference range for serum 25(OH)D concentrations being ≥ 30 ng/ml.
RESULTS
Of a total of 448 articles initially identified, 32 were selected for inclusion in the final analysis (Figure 1) . One study was excluded because it presented conflicting results between the prevalence of hypovitaminosis D and the maximum serum concentration of 25(OH)D reported. Most of the studies selected were cross-sectional cohort studies that employed the baseline measures required for inclusion in this review, although a few were case-control studies in of falls, and cognitive decline, as well as with an increased risk of Alzheimer's disease and depression
1
. Vitamin D is naturally produced by the skin, and exposure to ultraviolet radiation is a key step in its synthesis 7, 8 . Factors influencing that exposure, such as geographic location, cultural norms, skin color, use of sunscreen, and the modern lifestyle (more time spent indoors), can affect serum concentrations of 25-hydroxyvitamin D (25[OH]D).
Because human life expectancy has increased, many women live longer after menopause, when hypovitaminosis D can become more severe, not only because of the reduction in intestinal absorption due to the aging process but also because of the inherent hypoestrogenism in the postmenopausal period. In combination, these factors increase the risk of loss of bone mass 9 . From the above, it can be deduced that hypovitaminosis D can affect a large part of the population, and knowledge of its true population frequency can contribute to the formulation of public policies involving preventive measures and interventions 10 . Therefore, the objective of this systematic review was to evaluate the prevalence of hypovitaminosis D in postmenopausal women around the world.
METHODS
We conducted a search for cross-sectional studies that estimated the prevalence of hypovitaminosis D in postmenopausal women. We followed the recommendations established in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines
11
, selecting studies in which the serum concentrations of 25(OH)D had been determined in postmenopausal women and, although measurements over the 20 ng/mL limit are considered normal by important entities
12,13
, the 30 ng/ml (75 nmol/L) cut-off point had been used to distinguish between normality and insufficiency or deficiency because this is limit associated with the optimization of intestinal calcium absorption in postmenopausal women
14
. We excluded studies jointly evaluating women of reproductive age and postmenopausal women, studies that did not collect information regarding the menopausal status of the women, cohort studies of women with diseases, and case-control studies. When there was a control group comprising healthy postmenopausal women, data related to those women were included in the review, because the biochem- which the control group was representative of the population of interest. We also included eight poster publications that presented the necessary minimum information (Table 1) . Stratifying the results by continent, we found that the prevalence of hypovitaminosis D in North America, Europe, Africa, the Middle East, and Asia was 78.6%, 73.6%, 86,1% 81.5%, and 90.4%, respectively. The fact that the prevalence was highest in Asia was due to the study conducted in Beijing, which involved 1,724 women, almost all of whom had hypovitaminosis D
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. With the search strategy adopted, only one study from South America was selected, a study conducted in Argentina and involving 112 women, in Although comparisons were made among latitudes and continents, we identified no factors that could explain the differences observed. The reported prevalence of hypovitaminosis D was high even in populations in which the rate of vitamin D supplementation was near 50%
19
, or even above 60%
29
, although it was lower in the studies in which women receiving vitamin D supplementation were excluded
24
. We identified no association between the prevalence of hypovitaminosis D and the laboratory techniques employed.
DISCUSSION
One of the most important aspects of this review is the fact that, to our knowledge, this is the first study to show the worldwide distribution of the prevalence of hypovitaminosis D according to the laboratory technique employed, specific geographic location, and latitude. Another important aspect was the selection of studies involving healthy postmenopausal women, with the objective of avoiding biases caused by treatments or diseases concerning the serum concentrations of 25(OH)D. We chose to include studies in which a portion of the population was using vitamin D supplementation, as long as the samples were representative of the local population of healthy postmenopausal women.
In this review, we did not find the prevalence of hypovitaminosis D to be associated with geographic location, latitude, use of vitamin D supplementation, or the laboratory technique employed. We identified considerable variation among studies conducted in the same country, in terms of the prevalence of hypovitaminosis D. Between the two studies conducted in South Korea, the one conducted in 2009
23
, in which the prevalence of hypovitaminosis D was 44.0%, included women under treatment for osteoporosis or menopause, which could account for the difference in relation to the 2014 study 19 , which involved only women not receiving such treatment and in which the prevalence was 84.2%. It is of note that both of those studies were conducted in the city of Seoul. For the 2009 study 23 , if only the women not receiving vitamin D supplementation (n = 91) were evaluated, the prevalence would be 56%. In addition, the women evaluated by those authors were under treatment at a referral center for hormone replacement therapy or osteoporosis. Those treatments could have generated behavioral changes that had a positive influence on serum concentrations of 25(OH)D (engaging in outdoor activities, increased exposure to the sun, and consumption of foods rich in vitamin D). Similarly, in the United States, the prevalence of hypovitaminosis D ranged from as high as 81.5%, in a multicenter study 17 , to as low as 29.5%, in the study conducted in San Francisco
15
. Those two studies, however, were quite different. The first was an assessment of baseline serum 25(OH)D concentrations measured at the start of the follow-up of the Women's Health Initiative Observational Study, involving a total of 3,345 postmenopausal women followed at 40 clinical institutions throughout the United States, where approximately 50% of the participants were receiving vitamin D supplementation. The second study, conducted by Hacker-Thompson et al.
, involved a much smaller sample, comprising 122 participants, 82% of whom were receiving vitamin D supplementation. In addition, the laboratory technique used in both studies was HPLC, a technique described as being highly sensitive 1, 4 . In Saudi Arabia, blood samples were collected between January and May 2008 in the study conducted in the city of Al Khobar
24
, whereas they were collected throughout 2011 in the study conducted in the city of Jeddah
43
. However, the latter study provided no information on the laboratory technique used.
The countries of Europe were represented in 15 studies, the largest of which involved more than 8,500 postmenopausal women in nine countries 25 . In that study, serum 25(OH)D concentrations were determined by radioimmunoassay, although all of the laboratory techniques described in this review were used in at least one of the studies conducted in Europe. The prevalence of hypovitaminosis D was the lowest (62.0%) in Belgium and the highest (92.5%) in Spain. The high prevalence in the study conducted in Spain was not explained by geographic location or laboratory technique, and the most sensitive technique, HPLC, was used in that study. Morocco, the only African country represented in this review, accounted for three of the studies evaluated
30,32,36
, among which the prevalence ranged from 77.4%, in a study using electrochemiluminescence and collecting samples between November 2008 and October 2009 32 , to 92.0%, in a study using chemiluminescent immunoassay and collecting samples between June and August of an unspecified year
30
. These data did little to explain the difference found, given that the prevalence was higher in the study conducted only during the months of maximum solar radiation in that country . Researchers working in countries where Islam is the predominant religion often cite cultural and clothing issues as major factors inhibiting the endogenous production of vitamin D. In this review, we found that the mean prevalence of hypovitaminosis D in the Middle East was 78.6%, lower than that found in North America (81.4%), where the culture is very different from that of Muslim countries and the clothing designed for women does not necessarily cover their entire bodies. Therefore, we can't assume that the low serum concentrations of 25(OH)D reported for Muslim countries correlate with the type of clothing used.
Studies about hypovitaminosis D in postmenopausal women brings knowledge about a factor strongly associated with osteoporosis, which is particularly prevalent in this group. The knowledge about other population groups, such as premenopausal women, however, is desirable to allow comparisons that improve the understanding of hypovitaminosis D and its possible triggers.
This review has some limitations. The lack of standardization of the laboratory technique employed in the measurement of serum 25(OH)D concentrations and the different times of year during which the blood samples were collected made it difficult to compare the results across studies. Also, some studies with large sample sizes had to be excluded, some because they evaluated women with diseases such as osteopenia or osteoporosis and others because they did not present serum 25(OH)D concentrations with a cut-off point of 30 ng/ml. Furthermore, in some countries, a large part of the postmenopausal population use vitamin D supplementation, which creates a situation in which the potential vitamin D status of those populations could be masked. Nevertheless, we believe that this review has achieved its primary goals, showing the available information on the prevalence of hypovitaminosis D in postmenopausal women around the world and providing a global perspective on the problem.
CONCLUSION
The analysis of the selected studies revealed that the prevalence of hypovitaminosis D is high among postmenopausal women, affecting a large part of the population, even in the regions where that prevalence is lowest. Given the importance of vitamin D in women's health, further studies are needed in order to determine the actual impact of this finding. 
